Sócio Farmácia

Principais Atividades

Ensino de 1.º, 2.º e 3.º ciclos.
Investigação científica e desenvolvimento tecnológico.
Serviços de extensão universitária:
            serviços ao exterior
            atividades complementares no domínio da formação contínua e da promoção da inovação.

Órgãos

Presidente
Rogério Paulo Pinto de Sá Gaspar

Comissão Executiva de Departamento
(em atualização)

Comissão de Departamento
A Comissão de Departamento é constituída pelos Doutores do DSF com vínculo à FFUL.

Investigação

Instituto de Investigação do Medicamento (iMed.ULisboa)
            Grupo de Investigação:
            Farmacoepidemiologia e Sócio-Farmácia

2019

2018

2017

  • Advinha AM, Lopes MJ, de Oliveira-Martins S. Assessment of the elderly’s functional ability to manage their medication: a systematic literature review. International Journal of Clinical Pharmacy. 2017;39(1).
  • Arguello B, Salgado TM, Laekeman G, Fernandez-Llimos F. Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study. Regulatory Toxicology and Pharmacology. 2017;90:87–94.
  • Borba HH, Wiens A, Steimbach LM, Perlin CM, Tonin FS, Pedroso MLA, et al. Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24. European Journal of Clinical Pharmacology. 2017;73(1).
  • Borba HHL, Wiens A, Steimbach LM, Tonin FS, Pedroso MLA, Ivantes CAP, et al. Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: A multicenter longitudinal study. Therapeutics and Clinical Risk Management. 2017;13:59–64.
  • Cabral AC, Moura-Ramos M, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo IV. Cross-cultural adaptation of Hypertension Knowledge Test into European Portuguese. Brazilian Journal of Pharmaceutical Sciences. 2017;53(4).
  • Cabral AC, Moura-Ramos M, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo IV. Influence of the mode of administration on the results of medication adherence questionnaires. Journal of Evaluation in Clinical Practice. 2017;23(6):1252–7.
  • Carvalho M, Sepodes B, Martins AP. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework. Frontiers in Medicine. 2017;4.
  • Cavaco AM, Arslan M, Şar S. Informing the homeopathic practice for Turkish pharmacists: reviewing the example of Portuguese community pharmacies. Homeopathy. 2017;106(2):93–102.
  • Cavaco AM, Schaafsma E, Bicer BK, Sahne BS, Volmer D, Ozcelikay G, et al. Internet and computer use amongst european pharmacy undergraduates: Exploring similarities and differences. Farmacia. 2017;65(3):407–13.
  • da Costa FA, Teixeira I, Duarte-Ramos F, Proenca L, Pedro AR, Furtado C, et al. Effects of economic recession on elderly patients’ perceptions of access to health care and medicines in Portugal. International Journal of Clinical Pharmacy. 2017;39(1):104–12.
  • Fernandez-Llimos F, Minguet F, Salgado TM. New pharmacy-specific medical subject headings included in the 2017 database. American Journal of Health-System Pharmacy. 2017;74(15):1128–9.
  • Ferreira LN, Oliveira Martins S, Moital I, Ferreira P, Varela P, Oliveira H, et al. Assessing health-related quality of life in patients with psoriasis compared with the portuguese population. Value In Health. 2017;20(9):A763.
  • Gregório J, Cavaco AM, Lapão LV. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis. Research in Social and Administrative Pharmacy. 2017;13(1):133–47.
  • Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: Perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9).
  • Inacio P, Cavaco A, Airaksinen M. Patient ADR reporting through stakeholders’ lens: experiences in different EU countries. Drug Safety. 2017;40(10):986–7.
  • Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. British Journal of Clinical Pharmacology. 2017;83(2):227–46.
  • Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, et al. Diethylpropion and mazindol: An end to the discussion? Revista da Associacao Medica Brasileira. 2017;63(3):203–6
  • Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, et al. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics. 2017;72(5):317–24
  • Mair A, Fernandez-Llimos F, Alonso A, Harrison C, Hurding S, Kempen T, et al. Polypharmacy Management by 2030: a patient safety challenge. 2nd ed. Coimbra: SIMPATHY Consortium; 2017.
  • Mair A, Fernandez-Llimos F, Alonso A, Harrison C, Hurding S, Kempen T, et al. Polypharmacy Management by 2030: a patient safety challenge. Coimbra: SIMPATHY Consortium; 2017.
  • Mair A, Fernandez-Llimos F. Polypharmacy management programmes: The SIMPATHY Project. European Journal of Hospital Pharmacy. 2017;24(1):5–6.
  • Marques RP, Duarte GS, Sterrantino C, Pais HL, Quintela A, Martins AP, et al. Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 2017;118:54–62
  • Mateus V, Rocha J, Alves P, Mota-Filipe H, Sepodes B, Pinto R. Thiadiazolidinone-8 ameliorates inflammation associated with experimental colitis in mice. Pharmacology. 2017;101(1–2):35–42
  • Mateus V, Rocha J, Alves P, Mota-Filipe H, Sepodes B, Pinto RMA. Anti-Inflammatory Effect of Erythropoietin in the TNBS-induced Colitis. Basic and Clinical Pharmacology and Toxicology. 2017;120(2):138–45
  • Mendes T, Mousinho F, e Santos P, Viegas E, Madureira B, Gomes AP, et al. Burkimab protocol in the treatment of burkitt lymphoma associated with the infection of the human immunodeficiency virus: retrospective unicentric study. Haematologica. 2017;102(4):224.
  • Mendes T, Mousinho F, Sousa E Santos P, Viegas E, Gomes AP, Falcao F, et al. Immunohistochemistry biomarkers in patients with diffuse large b-cell lymphoma: a retrospective study. Haematologica. 2017 Jun;102(2):697–8.
  • Minguet F, Salgado TM, Santopadre C, Fernandez-Llimos F. Redefining the pharmacology and pharmacy subject category in the journal citation reports using medical subject headings (MeSH). International Journal of Clinical Pharmacy. 2017;39(5):989–97
  • Moorkens E, Vulto AG, Huys I, Dylst P, Godman B, Keuerleber S, et al. Policies for biosimilar uptake in Europe: An overview. PLoS ONE. 2017;12(12)
  • Mousinho F, e Santos P, Viegas E, Madureira B, Gomes AP, Falcao F, et al. Azacitidine in the treatment of myelodysplastic syndromes: retrospective analysis. Leukemia Research. 2017;55(1):S74.
  • Nunes-da-cunha I, Fernandez-Llimos F. Educational contents for a patient-centred undergraduate pharmacy curriculum. Lisboa: CIPF; 2017.
  • Oliveira AS, Guerreiro MP. ‘Everyone plays defence’: a qualitative exploration of issues that influence the prescribing of antibiotics by Portuguese dentists. Drugs and Therapy Perspectives. 2017;33(5):234–40
  • Oliveira Martins S, Moital I, Ferreira P, Oliveira H, Varela P, Cabrita J. Burden of arthritic manifestations on psoriatic patients - sub-analysis of pess oa, a patient reported outcomes study in portugal. Value In Health. 2017;20(9):A560.
  • Peres C, Matos AI, Conniot J, Sainz V, Zupančič E, Silva JM, et al. Poly(lactic acid)-based particulate systems are promising tools for immune modulation. Acta Biomaterialia. 2017;48:41–57
  • Pires C, Cavaco A, Vigario M. How sociodemographic features impact subjects’ opinion on packages leaflets of medicines? Australasian Medical Journal. 2017;10(9):774–84
  • Pires C, Cavaco A, Vigário M. Evaluation of brand names of medicines: linguistic and format issues. International Journal of Pharmacy Practice. 2017;25(3):231–7
  • Pires C, Cavaco A, Vigário M. Towards the Definition of Linguistic Metrics for Evaluating Text Readability. Journal of Quantitative Linguistics. 2017;24(4):319–49
  • Pires C, Martins F, Cavaco A, Vigário M. Automatic quantification of abbreviations in medicine package leaflets and their comprehension assessment. International Journal of E-Health and Medical Communications. 2017;8(2):47–64
  • Pires C, Vigário M, Cavaco A. Evaluation of the type and structure of the imprints used on the surface of medicines. Journal of Pharmacy Practice and Research. 2017;47(1):23–6
  • Praça FSG, Marinho HS, Martins MBF, Gaspar R, Corvo ML, Medina WSG. Current aspects of breast cancer therapy and diagnosis based on a nanocarrier approach. In: Ficai A, Grumezescu AM, editors. Nanostructures for Cancer Therapy. Amsterdam: Elsevier; 2017. p. 749–74.
  • Reis WC, Bonetti AF, Bottacin WE, Reis AS, Souza TT, Pontarolo R, et al. Impact on process results of clinical decision support systems (CDSSS) applied to medication use: Overview of systematic reviews. Pharmacy Practice. 2017;15(4)
  • Reis-Pardal J, Rodrigues A, Rodrigues E, Fernandez-Llimos F. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics. Pharmacogenomics Journal. 2017;17(6):488–93
  • Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Research In Social & Administrative Pharmacy. 2017;13(1):201–8
  • RRocha MJ, Castel-Branco M, Lopes VS, Vieira JP, Figueiredo I V, Fernandez-Llimos F. Factors associated to linezolid-induced thrombocytopenia. International Journal of Clinical Pharmacy. 2017;39(1):326.
  • Steimbach LM, Tonin FS, Virtuoso S, Souza AW, Fernandez-Llimos F, Pontarolo R. Nephrotoxicity of amphotericin-B lipid-based formulations versus conventional one: A systematic review and meta-analysis. International Journal of Clinical Pharmacy. 2017;39(1):325–6
  • Steimbach LM, Tonin FS, Virtuoso S, Souza AW, Fernandez-Llimos F, Pontarolo R. Nephrotoxicity of amphotericin-B lipid-based formulations versus conventional one: A systematic review and meta-analysis. International Journal of Clinical Pharmacy. 2017;39(1):325–6.
  • Stewart D, Gibson-Smith K, MacLure K, Mair A, Alonso A, Codina C, et al. A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS ONE. 2017;12(11)
  • Tonin FS, Steimbach LM, Borba HH, Sanches AC, Wiens A, Pontarolo R, et al. Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis. Journal of Pharmacy and Pharmacology. 2017;69(12):1672–83
  • Torre CM, Guerreiro J, Longo P, Filipe HM, Raposo JF, Leufkens H, et al. Real Life Drug USAGE of New Glucose Lowering Drugs (GLD): Results of an Intensive Monitoring Study in Portugal. Pharmacoepidemiology and Drug Safety. 2017;26(2):128.

2016

  • Advinha AM, Henriques A, Guerreiro MP, Nunes C, Lopes MJ, de Oliveira-Martins S. Cross-cultural validation of the Drug Regimen Unassisted Grading Scale (DRUGS) to assess community-dwelling elderly’s ability to manage medication. European Geriatric Medicine. 2016;7(5):424–9.
  • Araújo O, Lage I, Cabrita J, Teixeira L. Development and psychometric properties of ECPICID-AVC to measure informal caregivers’ skills when caring for older stroke survivors at home. Scandinavian Journal of Caring Sciences. 2016;30(4):821–9.
  • Cabral AC, Moura-Ramos M, Caramona M, Castel-Branco M, Figueiredo I V, Fernandez-Llimos F. Developing a maastricht utrecht adherence in Hypertension Questionnaire short version: MUAH16. International Journal of Clinical Pharmacy. 2016;38(5):1339–40.
  • Cabral AC, Rotta I, Caramona M, Castel-Branco M, Figueiredo I V, Fernandez-Llimos F. Assessing the homogeneousness in the use the 8-Items Morisky Medication Adherence Scale (MMAS-8). International Journal of Clinical Pharmacy. 2016;38(2):493.
  • Cavaco AM, Pires C, Vigario M. Linguistics metrics of package leaflets: estimating effects on users’ comprehension of medicines information. International Journal of Clinical Pharmacy. 2016;38(2):506.
  • Cláudio AP, Carmo MB, Guerreiro MP, Cavaco A, Pinto V, Pinha A. Virtual Humans playing the role of patients in self-medication consultations: Perspectives of undergraduate pharmacy students. In: VISIGRAPP 2016 - Proceedings of the 11th Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications. 2016. p. 298–305.
  • Corvo ML, Mendo AS, Figueiredo S, Gaspar R, Larguinho M, da Silva MFC, et al. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy. Pharmaceutical Research. 2016 Jun;33(6):1351–8.
  • Corvo ML, Mendo AS, Figueiredo S, Gaspar R, Larguinho M, Guedes da Silva MFC, et al. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy. Pharmaceutical Research. 2016;33(6):1351–8.
  • Dreischulte T, Fernandez-Llimos F. Current perceptions of the term Clinical Pharmacy and its relationship to Pharmaceutical Care: a survey of members of the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 2016;38(6):1445–56.
  • Duarte M, Ferreira P, Soares M, Martins AP, Cavaco A. Community pharmacists’ knowledge and perceptions on risk management plans in the Southern Region of Portugal. Clinical Research and Regulatory Affairs. 2016;33(2–4):33–8.
  • Fernandez-Llimos F, Melo L, Lavrador M, Caramona M, Figueiredo I V, Castel-Branco M. Association between necessities and concerns about medication and medication adherence in Brazilian ambulatory patients. International Journal of Clinical Pharmacy. 2016;38(2):497–8.
  • Fernandez-Llimos F, Vilela F, Reis W, Patriota B, Correr C. Comparison of three scales of drugs with anticholinergic effects on Brazilian polypharmacy population. International Journal of Clinical Pharmacy. 2016;38(2):476.
  • Fernandez-Llimos F. Bradford’s law, the long tail principle, and transparency in journal impact Factor calculations. Pharmacy Practice. 2016;14(3).
  • Florindo H, Lopes J, Silva L, Corvo M, Martins M, Gaspar R. Regulatory development of Nanotechnology-based vaccines. In: Micro- and Nanotechnology in Vaccine Development. Amsterdam: Elsevier; 2016. p. 393–410.
  • Gaffney VJ, Mota-Filipe H, Pinto RA, Thiemermann C, Loureiro M, Cardoso VV, et al. Chemical and biochemical characterization and in vivo safety evaluation of pharmaceuticals in drinking water. Environmental Toxicology and Chemistry. 2016;35(11):2674–82.
  • Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists’ interventions on clinical asthma outcomes: A systematic review. European Respiratory Journal. 2016;47(4):1134–43.
  • Guerreiro MP, Borges A, Cavaco A. Comparison of referral criteria for minor ailments from tertiary sources: preliminary results. International Journal of Clinical Pharmacy. 2016;38(2):474–5.
  • Leonardo C, Ruiz-Moral R, Caballero F, Cavaco A, Moore P, Paula Dupuy L, et al. A Latin American, Portuguese and Spanish consensus on a core communication curriculum for undergraduate medical education. BMC Medical Education. 2016 Mar;16.
  • Martins AP, Gonçalves E, Marcelo A, Vilão S, Da Silva JA. Pharmacy medicines not subject to medical prescription in Portugal: An underused access opportunity? | Medicamentos Não Sujeitos a Receita Médica de Dispensa Exclusiva em Farmácia em Portugal: Uma Oportunidade de Acesso Sub-Aproveitada? Acta Medica Portuguesa. 2016;29(9):542–8.
  • Martins J, Rodrigues J, Martins AP, Andreozzi V, Vandewalle B, Felix J, et al. Long-term effect of the Portuguese Universal Access Program to new generation direct-acting antivirals for the treatment of Hepatitis C. Journal of Hepatology. 2016;64(2):S778–9.
  • Mendes AE, Tonin FS, Fernandez-Llimos F. Analysis of ten years of publishing in pharmacy practice. Pharmacy Practice. 2016;14(4).
  • Mograo J, Da Costa CA, Gaspar R, Florindo HF. Modulation of dendritic cells by nanotechnology-based immunotherapeutic strategies. Journal of Biomedical Nanotechnology. 2016;12(3):405–34.
  • Moital I, Carrasco J, Adegas P, Cabrita J, Martins OS. Pessoa Study- Evaluating the burden of psoriasis in Portugal from the patients’ perspective (a patient reported outcomes analysis). Value In Health. 2016 Nov;19(7):A617.
  • Morais EM, Salgado TM, Gomez IV, Duarte AM, Fernandez-Llimos F. Differences in the information about procedures after cold chain disruption provided by pharmaceutical industry to hospital and community pharmacies. European Journal of Hospital Pharmacy. 2016;23(2):96–9.
  • Nunes-da-Cunha I, Arguello B, Martinez Martinez F, Fernandez-Llimos F. A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe. American Journal of Pharmaceutical Education. 2016;80(5).
  • Nunes-da-Cunha I, Fernandez-Llimos F. Systematic coding of pharmacy practice educational contents. Pharmaceutical Care Espana. 2016;18(1):28–42.
  • Pinho S, Ramalhinho I, Filipe Mota H. Antibiotic consumption in Portugal: 2010 and 2011. International Journal of Clinical Pharmacy. 2016;38(2):564.
  • Pires C, Vigário M, Cavaco A. Factors influencing subjects’ comprehension of a set of medicine package inserts. International Journal of Clinical Pharmacy. 2016;38(4):888–98.
  • Pires C, Vigário M, Cavaco A. Graphical content of medicinal package inserts: An exploratory study to evaluate potential legibility issues. Health Information and Libraries Journal. 2016;33(2):121–39.
  • Ramalhete N, Machado A, Serrano R, Gomes ET, Mota-Filipe H, Silva O. Comparative study on the in vivo antidepressant activities of the Portuguese Hypericum foliosum, Hypericum androsaemum and Hypericum perforatum medicinal plants. Industrial Crops and Products. 2016;82:29–36.
  • Ramalhinho IMPS, Magalhaes J, Pinho S, Ataide Ferreira J, Cavaco A, Mota Filipe H, et al. Urinary tract infections: outpatient antibiotic use and antimicrobial resistance in the Algarve Region. International Journal of Clinical Pharmacy. 2016;38(2):564.
  • Reis W, Lombardi N, Vilela F, Fernandez-Llimos F, Correr C. Regulatory differences among Brazilian, European and American official drug labelling. International Journal of Clinical Pharmacy. 2016;38(2):512.
  • Rodrigues J, Tato-Marinho R, Mota-Filipe H, Martins AP, Martins JC, Andreozzi V, et al. Evidence of Impressive Realworld SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C. Journal of Hepatology. 2016;64(2):S224.
  • Sabater-Galindo M, Fernandez-Llimos F, Sabater-Hernández D, Martínez-Martínez F, Benrimoj SI. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective. Patient Education and Counseling. 2016;99(3):339–47.
  • Sabater-Hernandez D, Moullin JC, Hossain LN, Durks D, Franco-Trigo L, Fernandez-Llimos F, et al. Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach. American Journal of Health-System Pharmacy. 2016;73(3):156–64.
  • Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, et al. A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease. Journal of Managed Care and Specialty Pharmacy. 2016;22(6):699–713.
  • Santos PS, Viegas E, Mousinho F, Baptista T, Reichert A, Gomes AP, et al. Antiretroviral therapy and chemotherapy in patients with HIV infection and haematological disease - toxicity assessment. Haematologica. 2016 Jun;101(1):490.
  • Seidling HM, Stuetzle M, Hoppe-Tichy T, Allenet B, Bedouch P, Bonnabry P, et al. Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions. International Journal of Clinical Pharmacy. 2016;38(2):362–73.
  • Sousa-Martins D, Sousa S, Duarte L, Monteiro M. Lutein reaches the retina following iontophoresis application. Investigative Ophthalmology & Visual Science. 2016;57(12).
  • Tato-Marinho R, Mota-Filipe H, Martins AP, Martins J, Rodrigues J, Andreozzi V, et al. Universal Access to new generation direct-acting antivirals to reduce the burden of Hepatitis C In Portugal. Journal of Hepatology. 2016;64(2):S816–7.
  • Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Iloperidone in the treatment of schizophrenia: An evidence-based review of its place in therapy. Core Evidence. 2016;11:49–61.
  • Torre C, Guerreiro J, Longo P, Leufkens H, Martins AP. New Glucose Lowering Drugs (Gld) Usage in Portugal: Results of an Intensive Monitoring Study in Real-Life Conditions. Pharmacoepidemiology and Drug Safety. 2016;25(S3):193.
  • Veiga P, Velez Lapao L, Miguel Cavaco A, Pereira Guerreiro M. Reporting pharmacy staff communication for OTC medicines encounters with simulated patients. International Journal of Clinical Pharmacy. 2016;38(2):503–4.
  • Zupančič E, Peres C, Matos AI, Lopes J, Moreira JN, Gaspar RS, et al. Translational peptide-associated nanosystems: Promising role as cancer vaccines. Current Topics in Medicinal Chemistry. 2016;16(3):291–313.

Atividades de Divulgação e Extensão Universitária

Contactos

Localização: Edifício H – C.3.13
Tel.: 217 946 457
Extensão interna: 14336
e-mail: rgaspar@ff.ulisboa.pt

Partilhar